VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TRS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TRSTriMas Corporation
$40.76$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

TRS logoTriMas Corporation(TRS)Earnings, Financials & Key Ratios

TRS•NASDAQ
$40.76
13.8× P/E·Price updated Jul 7, 2026
SectorConsumer CyclicalIndustryPackagingSub-IndustryPlastic Packaging (Rigid and Flexible)
AboutTriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.Show more
  • Revenue$646M-30.2%
  • EBITDA$71M-39.6%
  • Net Income$120M+395.4%
  • EPS (Diluted)2.95+400.0%
  • Gross Margin20.32%+1.4%
  • EBITDA Margin11.01%-13.5%
  • Operating Margin2.18%-61.9%
  • Net Margin18.61%+609.7%
  • ROE17.5%+387.3%

TRS Price & Volume

TriMas Corporation (TRS) stock price & volume — 10-year historical chart

Loading chart...

Non-Operating Gains Mask Structural Revenue Contraction

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Contracting
Profitability:Strained
Financial:Fortress
Cash Flow:Mixed
Primary Risk:Non-operating earnings distortion

Key Thesis Takeaways

  • TriMas Corporation is currently undergoing a significant transformation characterized by a 30.4% year-over-year revenue decline in 2026Q1 and a pivot toward a cash-heavy balance sheet.
  • While the company has successfully reduced its debt-to-equity ratio to 0.03, the reliance on non-recurring gains to drive a $800.8 million net income suggests that core operational performance remains strained.
  • Investors should monitor whether the $1.4 billion in net acquisitions and current liquidity buffer can stabilize long-term growth, as current operating margins of 4.1% indicate persistent challenges in achieving consistent profitability.

Verdict Logic

while the balance sheet is exceptionally clean with a 0.03 debt-to-equity ratio, the lack of core operational cash flow support and a 30.4% revenue decline warrant a cautious wait-and-see approach.

TRS Growth Metrics

TriMas Corporation (TRS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.87%
5 Years-3.46%
3 Years-9.93%
TTM-7.64%

Profit CAGR

10 Years-
5 Years-
3 Years22%
TTM2781.54%

EPS CAGR

10 Years-
5 Years-
3 Years23.66%
TTM3019.98%

Return on Capital

10 Years7.16%
5 Years5.76%
3 Years4.07%
Last Year1.14%

TRS Recent Earnings

TriMas Corporation (TRS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Apr 30, 2026
Metric
Actual
Est
EPS
$0.24+33.3%
$0.18
Rev
$168M+6.3%
$158M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.40-2.4%
$0.41
Rev
$155M-19.4%
$193M
Q4 2025
Oct 28, 2025
Metric
Actual
Est
EPS
$0.61+8.2%
$0.56
Rev
$269M+2.7%
$262M
Q3 2025
Jul 29, 2025
Metric
Actual
Est
EPS
$0.61+22.0%
$0.50
Rev
$275M+4.8%
$262M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$0.24vs $0.18+33.3%
$168Mvs $158M+6.3%
Q1 2026Feb 26, 2026
$0.40vs $0.41-2.4%
$155Mvs $193M-19.4%
Q4 2025Oct 28, 2025
$0.61vs $0.56+8.2%
$269Mvs $262M+2.7%
Q3 2025Jul 29, 2025
$0.61vs $0.50+22.0%
$275Mvs $262M+4.8%
Based on last 12 quarters of dataView full earnings history →

Latest TRS News

Recent stock market news and headlines for TriMas Corporation (TRS)

Zacks Investment Research·5 days ago
TriMas (TRS) Is Up 1.85% in One Week: What You Should Know

Does TriMas (TRS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Business Wire·Jun 30, 2026
TriMas Announces Second Quarter 2026 Earnings Conference Call Date

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it will hold its second quarter 2026 earnings conference call on Thursday, July 30, 2026, at 10 a.m. Eastern Time. The call will follow the Company's release of its earnings results earlier that morning at 8:00 a.m. Eastern Time.Earnings Call Access:U.S. & Canada: (877) 407-0890International: +1 (201) 389-0918Request: TriMas Second Quarter 2026 Earnings CallWebcast & slides: Available at www.trimas.com un.

Zacks Investment Research·Jun 16, 2026
Are You Looking for a Top Momentum Pick? Why TriMas (TRS) is a Great Choice

Does TriMas (TRS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Peers Comparison

Key metrics vs top competitors for TriMas Corporation (TRS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
TRS logoTRSTriMas CorporationCurrent
$40.76$1.53B13.82-30.19%18.61%17.5%0.4%
SLGN logoSLGNSilgan Holdings Inc.
$45.18$4.77B16.7310.73%4.31%12.47%—
APTV logoAPTVAptiv PLC
$58.85$12.45B78.473.47%1.77%3.81%—
ATR logoATRAptarGroup, Inc.
$127.69$8.22B21.725.42%9.98%18.64%—
CODI logoCODICompass Diversified
$10.05$756.12M-3.304.79%-12.3%-49.61%—
ESAB logoESABESAB Corporation
$94.02$5.72B25.273.71%7.12%9.5%—

Compare TRS vs Peers

TriMas Corporation (TRS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SLGN

Most directly comparable listed peer for TRS.

Scale Benchmark

vs DOW

Larger-name benchmark to compare TRS against a more recognizable public peer.

Peer Set

Compare Top 5

vs SLGN, APTV, ATR, CODI

TRS SEC Filings & Documents

TriMas Corporation (TRS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 18, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 2, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 28, 2025·SEC

FY 2025

Jul 29, 2025·SEC

Get notified when TRS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

TRS Frequently Asked Questions

TriMas Corporation (TRS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is TriMas Corporation's revenue?

TriMas Corporation (TRS) reported $867.8M in revenue for fiscal year 2025. This represents a 96% increase from $443.2M in 1993.

How fast is TriMas Corporation growing?

TriMas Corporation (TRS) saw revenue decline by 30.2% over the past year.

Is TRS profitable?

Yes, TriMas Corporation (TRS) is profitable, generating $908.5M in net income for fiscal year 2025 (18.6% net margin).

Dividend & Returns
Does TRS pay dividends?

Yes, TriMas Corporation (TRS) pays a dividend with a yield of 0.40%. This makes it attractive for income-focused investors.

What is TRS's return on equity?

TriMas Corporation (TRS) has a return on equity (ROE) of 17.5%. This is reasonable for most industries.

What is TriMas Corporation's free cash flow?

TriMas Corporation (TRS) generated $48.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in TRS back in 1993?

Total return calculator · dividends reinvested · 33+ years of data

See returns →